These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16488391)

  • 1. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
    Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
    Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on differentially expressed molecules influencing the metastatic potential between highly and poorly metastatic human lung giant cell carcinoma].
    Jiang DF; Lu YL; Qiu ZY; He FC
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):531-4. PubMed ID: 14690554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour.
    Rowe A; Jackson P
    Oncol Rep; 2006 Dec; 16(6):1267-72. PubMed ID: 17089048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
    Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C
    Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
    Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
    Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.
    Yang JM; Peng ZH; Si SH; Liu WW; Luo YH; Ye ZY
    Liver Int; 2008 Jan; 28(1):132-9. PubMed ID: 18028322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.
    Hung WC; Tseng WL; Shiea J; Chang HC
    Cancer Lett; 2010 Feb; 288(2):156-61. PubMed ID: 19625121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV; Kovacs G
    Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
    Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
    Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
    Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
    Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.